Medical News

RSS

Harden Healthcare receives $31.5M as part of $145M senior secured credit facility

GE Capital, Healthcare Financial Services has provided $31.5 million as part of a $145 million senior secured credit facility for Harden Healthcare, LLC. Harden will use the proceeds of the financing to provide additional growth capital and to refinance its existing debt facilities. GE Capital is the administrative agent for the credit facility. GE Capital Markets served as co-lead arranger and joint bookrunner.

18 Mar 2010

Novelos Therapeutics Phase 3 trial of NOV-002 in advanced NSCLC fails to meet primary and secondary endpoints

Novelos Therapeutics, Inc., a biopharmaceutical company focused on the development of therapeutics to treat cancer and hepatitis, today announced that primary and secondary endpoints were not met in Novelos’ pivotal Phase 3 trial in advanced non-small cell lung cancer (NSCLC) with its lead product, NOV-002, in combination with first-line chemotherapy.

18 Mar 2010

SGH recognized as winner of Microsoft HUG 2010 Innovation Awards

Eclipsys Corporation®, The Outcomes Company®, today announced that Singapore General Hospital, Singapore’s oldest and largest acute tertiary hospital and national referral center, has been recognized as a winner of the Microsoft HUG 2010 Innovation Awards in the category of “Best Use of Clinical Records — Inpatient.”

18 Mar 2010

ZIOPHARM Oncology reports fourth quarter net income of $1.0M against loss last year

ZIOPHARM Oncology, Inc., a biopharmaceutical company that is seeking to develop and commercialize a diverse, risk sensitive portfolio of in-licensed cancer drugs addressing unmet medical needs, announced today its financial results for the fourth quarter and full year 2009, and the filing of its Annual Report on Form 10-K with the Securities and Exchange Commission.

18 Mar 2010

Yellow fever outbreak in howler monkeys signals the need for human vaccination program

A group of Argentine scientists, including health experts from the Wildlife Conservation Society, have announced that yellow fever is the culprit in a 2007-2008 die-off of howler monkeys in northeastern Argentina, a finding that underscores the importance of paying attention to the health of wildlife and how the health of people and wild nature are so closely linked.

18 Mar 2010

Southern California’s Sexual Recovery Institute introduces additional Intensive Outpatient Programs

Southern California’s Sexual Recovery Institute (SRI), the leading outpatient treatment center for sex addiction, has announced additional Intensive Outpatient Programs (IOP). The expansion is a result of increased awareness of sex addiction issues as the mainstream media begins to shed light on high profile scandals and subsequent treatment methods.

18 Mar 2010

Manitoba government: AMD drug Lucentis will be funded through centralized vision program

Manitobans with wet age-related macular degeneration (AMD) received a dose of good news. The Manitoba government announced that Lucentis (ranibizumab injection) will soon be funded through a centralized vision program, effective June 1, 2010.

18 Mar 2010

Healthcare Reform: Congressman Chaka Fattah calls for single up-or-down vote

Congressman Chaka Fattah (D-PA) issues the following statement calling for a single up-or-down vote on Healthcare Reform:

18 Mar 2010

New program designed to improve law enforcement responses to the mentally ill

The Department of Justice's Office of Justice Programs today announced the release of a publication designed to improve law enforcement responses to people with mental illnesses. The report shows there is no one-size-fits-all approach, but a growing number of communities are implementing Specialized Policing Responses that are designed to improve outcomes and encounters involving people with mental illnesses.

18 Mar 2010

Nanobotmodels Company offer vision of future DNA and cell-repair techniques

Developments in nanotechnology and nanorobotics are opening up the prospects for nanomedicine and regenerative medicine where informatics and DNA computing can become the catalysts enabling health care applications at sub-molecular or atomic scales. While nanomedicine promises a new exciting frontier for clinical practice and biomedical research, issues involving cost-effectiveness studies, clinical trials and toxicity assays, drug delivery methods, and the implementation of new personalized therapies still remain challenging.

18 Mar 2010

SciQuest introduces PBA methodology for Life Sciences to improve procurement operations

SciQuest, Inc., the global software leader empowering enterprises to realize the potential of strategic procurement, today unveiled a comprehensive methodology that provides leaders with a framework to build and execute a sound business plan to improve existing procurement processes, systems and protocol. This new service, the Procurement Business Assessment (PBA), enables life sciences companies to quickly uncover cost-saving opportunities in their procurement operations.

18 Mar 2010

BMA Scotland comment on the publication of the Patient Rights

“BMA Scotland supports the Scottish Government’s aim to encourage a stronger sense of public ownership of the NHS and the renewed commitment to provide a service which is publicly funded and owned, free at the point of delivery. As such, we welcome the commitment to articulate the rights and responsibilities of all those using and providing NHS services.

18 Mar 2010

Tissue micro-processing solutions at volumes <1mL

At Analytica 2010 in Munich, Germany, Seward Ltd will demonstrate its small tissue processing solutions in Hall B2, Stand 130. This range includes the Stomacher® 80 microbag, designed specifically for use in the Stomacher 80 microBiomaster to prepare and process biological samples at volumes as low as 250µL to 5 mL.

18 Mar 2010

Academic Inventors’ Bill of Rights unveiled in poster presentation at AUTM Annual Meeting

As technology transfer managers from around the country prepare today to debate the role of academic researchers in commercializing their own inventions, two experts – one from each side of the aisle – have come together to propose an Academic Inventors’ Bill of Rights.

18 Mar 2010

Bailout stenting successful treatment for infants with constricted aortas

Cardiac interventionalists and surgeons at University Clinic in Leuven, Belgium have achieved successful stent implantation and follow-up coarctectomy in premature infants suffering from aortic coarctation. Full findings are published in the March issue of Catheterization and Cardiovascular Interventions, the official journal of The Society for Cardiovascular Angiography and Interventions.

18 Mar 2010

USPTO allows Regulus Therapeutics' claims covering methods of antagonizing miR-181a for regulating immune response

Regulus Therapeutics Inc. announced today that the United States Patent and Trademark Office (USPTO) has allowed claims in U.S. Application Serial No. 11/977,506 covering methods of antagonizing miR-181a to regulate immune response. This patent is owned by Stanford University and licensed exclusively to Regulus. miR-181a has been shown to regulate the response of immune cells, such as T lymphocytes, to specific stimuli and modulation of miR-181a could lead to a novel treatment of inflammatory disease.

18 Mar 2010

French National Program finds significant decreases in the rates of HAIs since 2004

Researchers evaluating France's national infection control program for healthcare facilities found significant decreases in the rates of healthcare-associated infections (HAIs) since 2004. The drop in HAIs, including MRSA and surgical site infections, could be attributed to important changes in the national infection control system.

18 Mar 2010

Risk of hereditary form of bowel cancer: New preparation of omega-3 holds hope

A new preparation of an omega-3 polyunsaturated fatty acid found naturally in fish, offers hope for thousands of patients at risk of developing an inherited form of bowel cancer, a new study shows.

18 Mar 2010

EndoChoice launches new CEU Video Program for reprocessing endoscopes

EndoChoice, Inc. strengthens its position as the leader in endoscopy industry with the launch of a new CEU program and a complete line of products focused on efficient and effective endoscope reprocessing.

18 Mar 2010

Haemonetics extends previously announced cash tender offer for Global Med Technologies

Haemonetics Corporation today announced that it is extending its previously announced cash tender offer, through its wholly-owned subsidiary Atlas Acquisition Corp., for all outstanding shares of common and preferred stock of Global Med Technologies, Inc., until 12:00 midnight, Boston, Massachusetts time, on Wednesday, March 24, 2010.

18 Mar 2010

Medical News

Harden Healthcare receives $31.5M as part of $145M senior secured credit facility

Novelos Therapeutics Phase 3 trial of NOV-002 in advanced NSCLC fails to meet primary and secondary endpoints

SGH recognized as winner of Microsoft HUG 2010 Innovation Awards

ZIOPHARM Oncology reports fourth quarter net income of $1.0M against loss last year

Yellow fever outbreak in howler monkeys signals the need for human vaccination program

Southern California’s Sexual Recovery Institute introduces additional Intensive Outpatient Programs

Manitoba government: AMD drug Lucentis will be funded through centralized vision program

Healthcare Reform: Congressman Chaka Fattah calls for single up-or-down vote

New program designed to improve law enforcement responses to the mentally ill

Nanobotmodels Company offer vision of future DNA and cell-repair techniques

SciQuest introduces PBA methodology for Life Sciences to improve procurement operations

BMA Scotland comment on the publication of the Patient Rights

Tissue micro-processing solutions at volumes <1mL

Academic Inventors’ Bill of Rights unveiled in poster presentation at AUTM Annual Meeting

Bailout stenting successful treatment for infants with constricted aortas

USPTO allows Regulus Therapeutics' claims covering methods of antagonizing miR-181a for regulating immune response

French National Program finds significant decreases in the rates of HAIs since 2004

Risk of hereditary form of bowel cancer: New preparation of omega-3 holds hope

EndoChoice launches new CEU Video Program for reprocessing endoscopes

Haemonetics extends previously announced cash tender offer for Global Med Technologies

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest News